Liquidia (NASDAQ:LQDA) Stock Price Down 2.8%

Liquidia Co. (NASDAQ:LQDA - Get Free Report)'s stock price fell 2.8% during trading on Tuesday . The stock traded as low as $14.70 and last traded at $14.70. 56,434 shares were traded during mid-day trading, a decline of 94% from the average session volume of 945,272 shares. The stock had previously closed at $15.13.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on LQDA. Wedbush reiterated an "underperform" rating and set a $3.00 price target on shares of Liquidia in a research report on Thursday, December 21st. LADENBURG THALM/SH SH upped their price target on shares of Liquidia from $15.00 to $30.00 and gave the stock a "buy" rating in a research report on Thursday, December 21st. Bank of America upped their price target on shares of Liquidia from $13.00 to $15.00 and gave the stock a "buy" rating in a research report on Thursday, December 21st. Needham & Company LLC reiterated a "buy" rating and set a $28.00 price target on shares of Liquidia in a research report on Monday, April 1st. Finally, HC Wainwright upped their price target on shares of Liquidia from $16.00 to $32.00 and gave the stock a "buy" rating in a research report on Thursday, March 14th. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $21.00.

Liquidia Trading Down 1.1 %

The stock has a market capitalization of $1.14 billion, a P/E ratio of -12.47 and a beta of 0.16. The company has a fifty day simple moving average of $14.68 and a two-hundred day simple moving average of $10.65.

Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Wednesday, March 13th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.23) by ($0.19). The firm had revenue of $4.53 million for the quarter, compared to the consensus estimate of $5.29 million. Liquidia had a negative return on equity of 132.16% and a negative net margin of 448.89%. As a group, analysts forecast that Liquidia Co. will post -1.01 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Jason Adair sold 4,657 shares of the company's stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $15.81, for a total value of $73,627.17. Following the completion of the sale, the insider now directly owns 108,640 shares of the company's stock, valued at approximately $1,717,598.40. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, insider Jason Adair sold 4,657 shares of the company's stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $15.81, for a total value of $73,627.17. Following the completion of the sale, the insider now directly owns 108,640 shares of the company's stock, valued at approximately $1,717,598.40. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Roger Jeffs sold 28,583 shares of the company's stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $15.82, for a total value of $452,183.06. Following the completion of the sale, the chief executive officer now directly owns 835,345 shares of the company's stock, valued at $13,215,157.90. The disclosure for this sale can be found here. In the last three months, insiders sold 54,605 shares of company stock valued at $862,904. 31.60% of the stock is currently owned by insiders.

Institutional Trading of Liquidia

Institutional investors and hedge funds have recently modified their holdings of the stock. Citigroup Inc. acquired a new position in shares of Liquidia in the 1st quarter valued at approximately $592,000. BlackRock Inc. grew its position in shares of Liquidia by 0.4% in the 1st quarter. BlackRock Inc. now owns 846,385 shares of the company's stock valued at $6,077,000 after purchasing an additional 3,042 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Liquidia by 56.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 74,307 shares of the company's stock valued at $534,000 after purchasing an additional 26,908 shares during the period. Vontobel Holding Ltd. acquired a new position in shares of Liquidia in the 1st quarter valued at approximately $86,000. Finally, Vanguard Group Inc. grew its position in shares of Liquidia by 2.9% in the 1st quarter. Vanguard Group Inc. now owns 1,659,082 shares of the company's stock valued at $11,912,000 after purchasing an additional 47,161 shares during the period. 64.54% of the stock is owned by institutional investors.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).